multiple sclerosis

Novartis’s Gilenya to Take 13% of Market in Year, Leerink Says
Bloomberg
Wed, 11/10/10 - 11:02 am
Novartis
Gilenya
MS
multiple sclerosis
Sanofi-Aventis starts Phase III oral-MS-drug test
Marketwatch
Tue, 10/26/10 - 11:17 am
MS
multiple sclerosis
Sanofi
teriflunomide
GfK HealthCare Study: Physicians Ready to Accept New Oral Therapy for MS
Trading Markets
Sun, 10/17/10 - 11:54 am
multiple sclerosis
Gilenya
Novartis
Early Initiation of Treatment with Copaxone (R) Provides Greater Effects in Delaying Conversion to Clinically Definite MS
Trading Markets
Sat, 10/16/10 - 09:41 am
Copaxone
multiple sclerosis
Teva Pharmaceuticals
Sanofi MS drug data show relapses cut by 31 pct
Reuters
Fri, 10/15/10 - 10:35 am
Sanofi
MS
multiple sclerosis
teriflunomide
Genzyme Says Campath MS Success Helps Justify Higher Sanofi Buyout Offer
Bloomberg
Thu, 10/14/10 - 05:19 pm
Genzyme
Campath
MS
multiple sclerosis
M&A
Sanofi
Genzyme sees signs of remission in 5-year MS drug data
Fierce Biotech
Thu, 10/14/10 - 11:53 am
MS
multiple sclerosis
Campath
Genzyme
Novartis to pay Gilenya patients' bills
Fierce Pharma
Thu, 10/7/10 - 11:52 am
Novartis
Gilenya
MS
multiple sclerosis
Novartis Gilenya Launch: The Importance of Health Care Reform
InVivo
Wed, 10/6/10 - 10:11 am
healthcare reform
Gilenya
Novartis
MS
multiple sclerosis
From Cicada Fungus To MS Drug: How Big Will Novartis’ New Pill Be?
Forbes
Mon, 09/27/10 - 11:59 am
Novartis
MS
multiple sclerosis
Gilenya
A Busy Week for Multiple Sclerosis News
Seeking Alpha
Sun, 09/26/10 - 12:24 pm
Novartis
Merck KGaA
Gilenya
multiple sclerosis
cladribine
Biogen Idec
Bayer
Teva Pharmaceuticals
Merck considers appeal of MS drug rejection
Financial Times, UK
Sat, 09/25/10 - 01:11 pm
Merck
multiple sclerosis
cladribine
Merck KGaA drops 10 per cent after drug rejection
FT.com
Fri, 09/24/10 - 09:57 am
Merck KGaA
MS
multiple sclerosis
Gilenya: A Blockbuster in Due Time
Motley Fool
Fri, 09/24/10 - 09:55 am
Gilenya
MS
multiple sclerosis
Novartis
Teva files new Copaxone lawsuit against Mylan
Yahoo/AP
Wed, 09/22/10 - 10:08 am
Teva Pharmaceuticals
Copaxone
patents
generics
MS
multiple sclerosis
Novartis gains FDA approval for Gilenya drug
Marketwatch
Wed, 09/22/10 - 09:53 am
FDA
Gilenia
Novartis
Gilenya
MS
multiple sclerosis
Novartis' Multiple Sclerosis Drug Gilenia Poised for Approval
Minyanville
Tue, 09/21/10 - 09:19 am
Novartis
Gilenia
FDA
MS
multiple sclerosis
Glaxo and Genmab drop IV version of immune drug
Yahoo/AP
Thu, 09/16/10 - 12:15 pm
GSK
Genmab
Arzerra
autoimmune disease
multiple sclerosis
Xenoport rallies on drug update; indexes gain
Marketwatch
Mon, 09/13/10 - 12:53 pm
XenoPort
arbaclofen placarbil
MS
multiple sclerosis
Yet Another Reason That Sanofi-Genzyme Deal Will Go Through
BNET Pharma
Fri, 09/10/10 - 11:10 am
M&A
Sanofi
Genzyme
teriflunomide
MS
Campath
multiple sclerosis

Pages